SCM
AGRX

Sio Capital Management’s Agile Therapeutics AGRX Stock Holding History

Sio Capital Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-83
Closed -$1.03M – 56
2016
Q1 		$1.03M Buy
83
+46
+124% +$594K 0.38% 35
2015
Q4 		$725K Sell
37
-3
-8% -$47.5K 0.32% 37
2015
Q3 		$536K Buy
40
+9
+29% +$160K 0.37% 30
2015
Q2 		$538K Sell
31
-71
-70% -$1.52M 0.27% 35
2015
Q1 		$1.89M Sell
102
-273
-73% -$4.78M 1.08% 22
2014
Q4 		$4.6M Buy
+375
New +$4.77M 3.62% 10

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sio Capital Management's AGRX Position: Q2 2016 in Review

Sio Capital Management sold out of Agile Therapeutics (AGRX) in Q2 2016, closing a stake of 83 shares — an estimated $1.03M sold.

Sio Capital Management first reported a position in AGRX in Q4 2014 and held it in 6 quarters. The position peaked at $4.6M in Q4 2014. 50 funds tracked by Wall St. Rank hold AGRX as of Q2 2016.

  • Sio Capital Management reported no remaining Agile Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Sio Capital Management sold 83 Agile Therapeutics shares in Q2 2016, an estimated $1.03M.
  • Sio Capital Management first reported a position in Agile Therapeutics in Q4 2014 and held it in 6 quarters.
  • Sio Capital Management's Agile Therapeutics position peaked at $4.6M in Q4 2014.
  • 50 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2016.

Based on Sio Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.